Latest filing published 06 May 2025 for Xencor Inc, €45k. Read the official filing
Nancy Valente is a declared insider at 2 companies; the most frequent names are Xencor Inc and Myovant Sciences Ltd. We count 7 filings; the first trade dates from 26 October 2022 and the latest from 2 May 2025.
No open-market purchase appears, only 3 sales worth €181k. The rest of the record consists of 3 share grants. Since January 2025: no purchases and 2 sales on the market.
The latest filing, published on 6 May 2025, reports an open-market sale of €45k in Xencor Inc. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. Section 16 rules allow two business days to file each Form 4. Selling is not necessarily a view on the stock: liquidity needs and diversification are common motives. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
7 of 7 declarations